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The application of nanotechnology in the health care setting has many potential benefits; 
however, our understanding of the interactions between nanoparticles and our immune 
system remains incomplete. Although many of the biological effects of nanoparticles 
are negatively correlated with particle size, some are clearly size specific and the 
mechanisms underlying these size-specific biological effects remain unknown. Here, we 
examined the pro-inflammatory effects of silica particles in THP-1 cells with respect to 
particle size; a large overall size range with narrow intervals between particle diameters 
(particle diameter: 10, 30, 50, 70, 100, 300, and 1,000 nm) was used. Secretion of the 
pro-inflammatory cytokines interleukin (IL)-1β and tumor necrosis factor (TNF)-α induced 
by exposure to the silica particles had a bell-shaped distribution, where the maximal 
secretion was induced by silica nanoparticles with a diameter of 50 nm and particles 
with smaller or larger diameters had progressively less effect. We found that blockade 
of IL-1β secretion markedly inhibited TNF-α secretion, suggesting that IL-1β is upstream 
of TNF-α in the inflammatory cascade induced by exposure to silica particles, and that 
the induction of IL-1β secretion was dependent on both the NLRP3 inflammasome and 
on uptake of the silica particles into the cells via endocytosis. However, a quantitative 
analysis of silica particle uptake showed that IL-1β secretion was not correlated with 
the amount of silica particles taken up by the cells. Further investigation revealed that 
the induction of IL-1β secretion and uptake of silica nanoparticles with diameters of 50 
or 100 nm, but not of 10 or 1,000 nm, was dependent on scavenger receptor (SR) A1. 
In addition, of the silica particles examined, only those with a diameter of 50 nm induced 
Abbreviations: nSP10, nSP30, nSP50, nSP70, nSP100, mSP300, and mSP1000, amorphous silica particles with diameters of 10, 
30, 50, 70, 100, 300, and 1,000 nm, respectively; silica particles, amorphous silica particles; crystalline silica, crystalline silica 
particles; PMA, phorbol 12-myristate 13-acetate; poly I, polyinosinic acid potassium salt; ATP, adenosine 5′-triphosphate diso-
dium salt hydrate; ICP-AES, inductively coupled plasma atomic emission spectrometry; FLICA, fluorescent-coupled YVAD 
inhibitor to the activated form of caspase-1; SR, scavenger receptor; MARCO, macrophage receptor with collagenous structure.
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inTrODUcTiOn
The application of nanotechnology is a promising means of 
developing novel diagnostic and imaging technologies, photo-
thermal therapies, vaccines, and drug delivery systems (1–3). 
However, various immune toxicities associated with exposure to 
nanoparticles have been reported, including inflammation (4), 
immune suppression (5), IgE-biased immune responses (6), and 
the induction of metal allergies (7). Therefore, improving our 
understanding of the interactions between nanoparticles and our 
immune system is essential to ensure the safe use of nanotechnol-
ogy in the health care setting.
There are two main factors that make nanoparticles not only 
more effective but also more hazardous than the bulk material. 
The first is their ability to cross biological barriers [e.g., blood–
brain barrier (8), placental barrier (9), blood–milk barrier (10), 
and nuclear barrier (11)]. The second is their large surface area 
per unit mass due to their small particle size. Since biological 
interactions occur on the surface of nanoparticles, the biological 
activity of nanoparticles per unit mass increases as particle size 
decreases (12). Indeed, many studies, both in vitro and in vivo, 
have demonstrated that smaller nanoparticles have biological 
activities of greater strength compared with larger particles 
(13–16). However, several in vitro studies have also shown that 
nanoparticles with a diameter of 50 nm are more readily taken up 
by cells and/or have greater cytotoxicity than larger and smaller 
particles of the same material (17–20). Indeed, we recently identi-
fied a size-specific effect in mice, where silica nanoparticles with 
a diameter of 50 nm induced the most severe hypothermia in the 
10–1,000 nm size range (21). In addition, it has been reported 
that in a comparison of nanoparticle-based antitumor vaccines 
that differed only with respect to particle diameter (20, 40, 
100, 200, 500, 1,000, or 2,000  nm), the vaccine with a particle 
diameter of 40 nm was the most effective (22). Together, these 
studies demonstrate not only that size-specific biological effects 
of nanoparticles exist but also that particles with diameters of 
around 50  nm induce the strongest biological effects. Further 
studies are needed to elucidate the mechanisms underlying these 
size-specific effects.
The pro-inflammatory effects of nanoparticles are well 
described in the literature and are a major issue for the devel-
opment of safe nanomedicines (23). In particular, the NLRP3 
inflammasome-mediated pro-inflammatory effects of nanoparti-
cles have been reported (4, 24–26). However, the effect of particle 
size on the pro-inflammatory effects of nanoparticles is poorly 
understood, most likely because previous studies did not examine 
a particle size range that included fine enough intervals between 
particle sizes.
In the present study, we examined the effects of particle size 
on the pro-inflammatory response of THP-1 cells to exposure to 
silica particles within a large overall size range (10–1,000  nm) 
that included narrow intervals between the particle diameters. 
We also explored the mechanisms underlying this size-specific 
inflammatory response in our model, although it should be noted 
that the experimental conditions were not chosen to represent 
human exposure scenarios.
MaTerials anD MeThODs
silica Particles
Amorphous silica particles (silica particles) with diameters of 10, 
30, 50, 70, 100, 300, or 1,000 nm (nSP10, nSP30, nSP50, nSP70, 
nSP100, mSP300, and mSP1000, respectively) were purchased 
from Micromod Partikeltechnologie (Rostock/Warnemünde, 
Germany). Crystalline silica particles (Min-U-Sil-5; crystalline 
silica in diameter of not bigger than 5 µm) were purchased from 
Pennsylvania Sand Glass Corporation (Pittsburgh, PA, USA). 
The endotoxin level of each size of silica particle (50 µg/mL in 
cell culture media) was 0.25, 0.15, 0.11, 14.88, 1.23, 0.01, and 
<0.01 endotoxin units/mL for nSP10, nSP30, nSP50, nSP70, 
nSP100, mSP300, and mSP1000, respectively, as determined 
by a Pyros Kinetix turbidity assay instrument with a limit of 
detection of 0.001 endotoxin units/mL. Endotoxin testing was 
performed on our behalf by nanoComposix (San Diego, CA, 
USA). Immediately prior to use, the dispersions of the particles 
were sonicated at 400 W for 5 min at 25°C and then vortexed 
for 1 min.
reagents
Phorbol 12-myristate 13-acetate (PMA), polyinosinic acid potas-
sium salt (poly I), cytochalasin D, bafilomycin A1, BMS345541, 
and adenosine 5′-triphosphate disodium salt hydrate (ATP) were 
purchased from Sigma Aldrich (St. Louis, MO, USA). zYVAD-
fmk and UNC569 were purchased from Merck (Darmstadt, 
Germany).
ThP-1 cells
THP-1 cells (human acute monocytic leukemia cell line) were 
obtained from the American Type Culture Collection (Manassas, 
VA, USA) and cultured at 37°C (95% room air, 5% CO2) in 
RPMI1640 (Wako Pure Chemical Industries, Osaka, Japan) sup-
plemented with 10% fetal bovine serum, 1% antibiotic cocktail 
(10,000 U/mL penicillin, 10,000 µg/mL streptomycin, and 25 µg/
mL amphotericin B; Gibco, BRL, Bethesda, MD, USA), and 
2-mercaptoethanol (50 µM; Gibco).
strong IL-1β secretion via activation of Mer receptor tyrosine kinase, a signal mediator 
of SR A1. Together, our results suggest that the SR A1-mediated pro-inflammatory 
response is dependent on ligand size and that both SR A1-mediated endocytosis and 
receptor-mediated signaling are required to produce the maximal pro-inflammatory 
response to exposure to silica particles.
Keywords: inflammasome, Mer receptor tyrosine kinase, nanoparticles, nanotoxicity, scavenger receptor, size
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evaluation of the Pro-inflammatory 
activity of the silica Particles
THP-1 cells (3.0  ×  104 cells/well) were seeded in flat-bottom 
96-well plates (Nunc, Rochester, NY, USA) and then differentiated 
into macrophages by incubation with 0.5 µM PMA at 37°C for 
24 h. After incubation, the cells were washed with the cell culture 
media and treated with the silica particles, crystalline silica, or ATP. 
After incubation for 6, 12, or 24 h, the supernatants were collected. 
To determine cell viability after exposure to the test materials, the 
concentration of lactate dehydrogenase in the supernatants was 
measured by using a Cytotoxicity LDH Assay Kit (Wako, Osaka, 
Japan) in accordance with the manufacturer’s instructions. To 
evaluate the pro-inflammatory response to exposure to the test 
materials, the concentrations of the pro-inflammatory cytokines 
interleukin (IL)-1β and tumor necrosis factor (TNF)-α, and of 
the receptor antagonist (RA) IL-1RA, in the supernatants were 
assessed by ELISA kits (IL-1β, BD Pharmingen, San Diego, CA, 
USA; TNF-α, eBioscience, San Diego, CA, USA; IL-1RA, R&D 
Systems, Minneapolis, MN, USA) in accordance with the manu-
facturers’ instructions. In inhibitory and neutralizing antibody 
assays, cytochalasin D, zYVAD-fmk, BMS345541, bafilomycin 
A1, anti-human scavenger receptor (SR) A1 monoclonal anti-
body (351620) (R&D Systems) or its mouse IgG1 isotype control 
(BioLegend, San Diego, CA, USA), anti-human macrophage 
receptor with collagenous structure (MARCO) antibody (PLK1) 
(Hycult Biotech, Uden, The Netherlands) (27) or its mouse IgG3 
isotype control (BioLegend), recombinant human IL-1RA (R&D 
systems), or anti-human IL-1β/IL-1F2 (2805) (R&D systems) 
were added to the wells containing the PMA-differentiated THP-1 
cells 30 min before stimulation with the test materials.
Western Blotting analysis
THP-1 cells (9.0 ×  105 cells/well) were seeded in 6-well plates 
(Nunc) and then differentiated into macrophages by incubation 
with 0.5 µM PMA at 37°C for 24 h. After incubation, the cells 
were washed with the cell culture media and treated with the 
silica particles (50 µg/mL), crystalline silica (500 µg/mL), or ATP 
(3 mM). After incubation for 6, 12, or 24 h, the cells were washed 
twice with phosphate-buffered saline and lysed with Mammalian 
Protein Extraction Reagent (M-PER; Thermo Fisher Scientific, 
Rockford, IL, USA). Protein samples (1  µg) were loaded on a 
20% sodium dodecyl sulfate–polyacrylamide gel. After electro-
phoresis, proteins were transferred to polyvinylidene difluoride 
membranes (GE Healthcare, Buckinghamshire, UK). The blots 
were blocked with 1% BSA in phosphate-buffered saline with 
0.02% Tween 20 for 2  h at room temperature. The blots were 
incubated with monoclonal antibody to human IL-1β/IL-1F2 
(8516) (R&D systems) at 1 h. HRP-conjugated goat anti-mouse 
antibody (SouthernBiotech, Birmingham, AL, USA) was added 
to the membranes, which were then incubated for 1 h at room 
temperature. The protein bands on the membrane were visualized 
with SuperSignal West Femto Maximum Sensitivity Substrate 
(Thermo Fisher Scientific), and the images were captured by 
LAS4000 mini (GE Healthcare). The densities of the bands in 
the captured image were analyzed by using the ImageJ software 
(version 1.46r, National Institutes of Health).
inductively coupled Plasma atomic 
emission spectrometry (icP-aes) analysis
THP-1 cells (1.4 × 107 cells/dish) were seeded in 150-mm dishes 
and differentiated into macrophages by incubation with 0.5 µM 
PMA at 37°C for 24 h. After incubation, the cells were washed 
with phosphate-buffered saline and incubated with 50  µg/mL 
of each test material for 6, 12, or 24 h. In a neutralization assay, 
PMA-differentiated THP-1 cells were pre-incubated for 30 min 
with anti-human SR-A1 or its isotype control at a concentra-
tion of 0.4 µg/mL. After incubation with the test materials, the 
supernatant was removed and the cells were washed twice with 
phosphate-buffered saline. The cells were then detached from the 
dish surface using trypsin, washed with the cell culture media, 
and collected. After the cells were collected, samples from three 
dishes were pooled for analysis. The pooled cells were counted, 
suspended in 1  mL of MilliQ water, and sent to Japan Food 
Research Laboratories (Osaka, Japan), where the samples were 
prepared for ICP-AES analysis as follows: the cells were heated to 
500°C and ash melted with sodium carbonate. Water was added 
to the residue and the mixture was heated for 30 min before being 
passed through filter paper. The filtrates were then brought to a 
volume of 50 mL with ultrapure water. The mass of silicon in each 
sample was then measured with a Vista-MPX ICP-AES instru-
ment (Varian, Palo Alto, CA, USA) on our behalf by Kiyokawa 
Plating Industry Co., Ltd. (Fukui, Japan). Silicon uptake by the 
cells was calculated as the amount of silicon in silica particle-
treated cells minus the silicon level in non-silica-treated cells.
statistical analyses
Statistical analyses were performed by using the Ekuseru-Toukei 
2012 software (Social Survey Research Information Co., Ltd., 
Tokyo, Japan). Data are presented as mean ±  SD. Significant 
differences between the control group and experimental group 
were assessed by using Student’s t-test. P < 0.05 was considered 
statistically significant.
Methods used in the Supplementary Figures are in the sup-
plementary figures file.
resUlTs
effect of Particle size on the Pro-
inflammatory effect of silica Particles in 
ThP-1 cells
The hydrodynamic diameters of the silica particles dispersed 
in the cell culture medium (5  mg/mL), as measured by means 
of dynamic light scattering, were 10.0, 24.3, 48.3, 64.7, 86.0, 
285.7, and 1,164.3 nm for nSP10, nSP30, nSP50, nSP70, nSP100, 
mSP300, and mSP1000, respectively (Table S1 in Supplementary 
Material). These hydrodynamic diameters suggest that the 
silica particles were well dispersed in the cell culture medium. 
Transmission electron microscopy images of the silica particles 
used in the present study are provided in our previous reports 
(6, 21, 28).
We first evaluated the cytotoxicity of the silica particles in 
THP-1 cells by means of a lactate dehydrogenase cytotoxicity 
FigUre 1 | effects of silica particles on ThP-1 cell viability and pro-inflammatory cytokine secretion. Phorbol 12-myristate 13-acetate-differentiated 
THP-1 cells were incubated with silica particles of various concentrations for 6, 12, or 24 h. After incubation, culture supernatants were collected. (a) Cell viability 
was determined by means of a lactate dehydrogenase assay. (B) Interleukin (IL)-1β and tumor necrosis factor (TNF)-α concentration in the culture supernatant was 
measured by ELISA. Data are presented as mean ± SD (n = 4 independent cultures/group). N.D., not detected.
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assay (Figure  1A). PMA-differentiated THP-1 cells were incu-
bated with the different silica particles (nSP10, nSP30, nSP50, 
nSP70, nSP100, mSP300, or mSP1000) for 6, 12, or 24  h. We 
hardly detected cytotoxicity in our dose range at 6 and 12 h. On 
the other hand, dose-dependent cytotoxicity was observed at a 
dose greater than 100 µg/mL in all of the silica particle-treated 
groups at 24 h and the data suggested that larger particles tended 
to induce stronger cytotoxicity. In the following assays, 50 µg/mL 
was the maximum dose of silica particles used to avoid inducing 
cytotoxicity.
To examine the effect of particle size on the pro-inflammatory 
effects of the silica particles in THP-1 cells, we measured the 
concentration of the pro-inflammatory cytokines IL-1β and 
TNF-α in the culture supernatant after incubation of the cells 
5Nishijima et al. Size-Specific Effect of Nanoparticles
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with the silica particles for 6, 12, or 24 h (Figure 1B). Although 
incubation with the silica particles for 6 or 12 h had little effect 
on the secretion of IL-1β and TNF-α, incubation for 24 h resulted 
in a marked increase in the concentrations of IL-1β and TNF-α 
in the supernatant in several of the silica particle-treated groups. 
Furthermore, a bell-shaped size-specific effect was observed, 
where the silica particles with a diameter of 50 nm induced the 
greatest secretion of IL-1β and TNF-α and silica particles with 
smaller or larger diameters had progressively less effect (overall 
size range, 10–1,000  nm). In addition, the transcript levels of 
IL-1β and TNF-α were increased 24 h after incubation with nSP50 
compared with the control group (Figure S1 in Supplementary 
Material), which was consistent with the results regarding the 
secreted proteins. As a positive control, we also exposed the cells 
to crystalline silica and ATP, which has known pro-inflammatory 
effects, and found that with this exposure the secretion of IL-1β 
was increased at the 6, 12, and 24-h time points (Figure S2 in 
Supplementary Material), which is consistent with a previous 
report (29). Thus, the size-specific pro-inflammatory effects of 
silica particles had a relatively slow onset compared with that of 
crystalline silica as a control particle.
It has been reported that the induction of TNF-α production 
by crystalline silica is mediated by IL-1β (29), which implies that 
the observed increase in TNF-α secretion by exposure to the 
silica particles may also be meditated by IL-1β. We, therefore, 
examined the effect of inhibiting IL-1 signaling on the silica 
particle-induced secretion of TNF-α. Co-incubation of the cells 
with the silica particles (nSP10, nSP50, nSP100, and mSP1000 
as representatives of the size effect) and the RA IL-1RA resulted 
in a marked reduction in the amount of TNF-α secreted by cells 
incubated with nSP50 (Figure  2A, left). Similar results were 
obtained after co-incubation of the cells with the silica particles 
and anti-IL-1β (Figure 2B). Together, these results suggest that 
the induction of TNF-α by the silica particles was completely 
dependent on the production of IL-1β. Furthermore, co-incuba-
tion with IL-1RA was found to suppress the secretion of IL-1β in 
nSP50- or mSP1000-treated cells, but not in nSP10- or nSP100-
treated cells, suggesting that a positive feedback loop is created 
for IL-1β in nSP50- or mSP1000-treated cells (Figure 2A, right). 
We speculated that perhaps nSP50 inhibited endogenous IL-1RA 
production, which would enhance the effect of IL-1β. However, 
the concentration of IL-1RA in the culture supernatants of the 
cells exposed to the silica particles was comparable with that in 
the supernatants of unstimulated cells (Figure 2C).
Two processes are involved in the secretion of mature IL-1β: 
NF-κB-dependent pro-IL-1β synthesis and NLRP3 inflam-
masome (caspase-1)-dependent cleavage of pro-IL-1β (30). 
Therefore, next we evaluated the effect of exposure to the silica 
particles on these two processes. Blocking the maturation of 
IL-1β with zYVAD-fmk, a caspase-1 inhibitor, considerably 
reduced the concentration of IL-1β in the culture supernatants 
of the silica particle-treated cells and in the crystalline silica- or 
ATP-treated cells, which were positive controls for activation of 
the NLRP3 inflammasome (30) (Figure 3A). These results sug-
gest that induction of IL-1β by silica particles is dependent on the 
NLRP3 inflammasome. In addition, flow cytometric evaluation 
of the binding of a fluorescence-coupled YVAD inhibitor of 
caspase-1 activation showed that caspase-1 tended to be activated 
in cells treated with nSP10, nSP50, nSP100, or mSP1000 (Figure 
S3A in Supplementary Material).
Particulate matter such as crystalline silica and alum is known 
to activate the NLRP3 inflammasome via lysosomal destabiliza-
tion, and neutralization of lysosomal pH inhibits this activation 
pathway (30). In the present study, inhibiting lysosomal acidifica-
tion by co-incubation with bafilomycin A1, an inhibitor of vacuo-
lar-type H+-ATPase, reduced the induction of IL-1β by all of the 
silica particles or crystalline silica, but not that induced by ATP 
(Figure 3B), which is independent of lysosomal destabilization 
(31). Furthermore, we found that loss of the red acidity-dependent 
acridine orange signal, which is an index of lysosomal integrity, 
was significantly increased in nSP50- or crystalline silica-treated 
cells, but not in ATP-treated cells (Figure S2B in Supplementary 
Material). The loss of the red acidity-dependent acridine orange 
signal appeared to be enhanced in nSP10- or nSP100-treated cells 
(Figure S3B in Supplementary Material). These findings suggest 
that, like crystalline silica, silica particles activate the NLRP3 
inflammasome via lysosomal destabilization (32). Thus, the 
present results show that the silica particles induced the secretion 
of IL-1β via activation of the NLRP3 inflammasome. The results 
imply that nSP50 activated the NLRP3 inflammasome more than 
did the other sizes of silica particles via stronger induction of 
lysosomal destabilization (Figure S3 in Supplementary Material).
We next examined the effects of silica particle size on the induc-
tion of pro-IL-1β. Since we detected pro-IL-1β in untreated cells, 
PMA-differentiation has induced a certain amount of pro-IL-1β, 
which is consistent with a previous report (Figures 3C,D) (32). 
The expression of pro-IL-1β was increased in cells incubated with 
ATP for 12 or 24 h (Figures 3C,D). In addition, nSP50 induced 
more pro-IL-1β compared with the other silica particles after 
incubation for 24 h (Figures 3C,D). This induction of pro-IL-1β 
further confirms that a positive feedback loop for IL-1β is created 
in nSP50-treated cells (Figure 2A, 24 h).
relationship between cellular Uptake and 
the size-specific Pro-inflammatory effect 
of silica Particles
It is well known that endocytosis of particulate matter triggers the 
pro-inflammatory responses. We, therefore, evaluated whether 
the size-specific pro-inflammatory effect of silica particles was 
endocytosis dependent. Blocking actin-dependent endocytosis 
with cytochalasin D, a potent inhibitor of actin polymerization, 
completely suppressed the induction of IL-1β in the silica particle- 
or crystalline silica-treated cells (Figure 4A). This result suggests 
that the induction of IL-1β by the silica particles or crystalline 
silica was dependent on actin-dependent endocytosis. Therefore, 
we hypothesized that the size-specific pro-inflammatory effects 
of the silica particles were a result of greater uptake of nSP50 than 
of the other sizes of silica particles. We, therefore, quantitatively 
measured by means of ICP-AES the amount of silicon inside 
cells exposed to the silica particles. A time-dependent increase 
in the uptake of silica particles was observed in all of the silica 
particle-treated cells (Figure 4B). The greatest concentration of 
silicon was found in the cells treated with mSP1000, whereas 
FigUre 2 | role of interleukin (il)-1β in the pro-inflammatory effects of silica particles. Phorbol 12-myristate 13-acetate-differentiated THP-1 cells were 
incubated with IL-1 receptor antagonist (IL-1RA) (a) or anti-IL-1β (B) 30 min before the addition of silica particles (50 µg/mL). After incubation for 24 h, the 
concentration of IL-1β (a,B) and tumor necrosis factor (TNF)-α (a) in the culture supernatant was measured by ELISA. (c) Phorbol 12-myristate 13-acetate-
differentiated THP-1 cells were incubated with silica particles (50 µg/mL) for 6, 12, or 24 h. After incubation, IL-1RA concentration in the culture supernatants was 
determined by ELISA. Data are presented as mean ± SD (n = 4 independent cultures/group). N.D., not detected.
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the least was found in the cells treated with nSP50 (Figure 4B, 
left panel). By using the concentration of silicon in the cells to 
calculate the surface area and number of silica particles taken 
up, we found that nSP10-treated cells contained the greatest total 
particle surface area and number of silica particles (Figure 4B, 
center and right panels). Therefore, the induction of IL-1β by the 
silica particles was not correlated with the total mass of silicon, 
the total particle surface area, or the number of silica particles 
taken up by the cells, even though IL-1β secretion appeared to 
be completely dependent on the uptake of the silica particles via 
actin-dependent endocytosis. We, therefore, hypothesized that a 
specific mode of endocytosis that is only used for the uptake of 
silica particles in a specific size range was responsible for their 
observed size-specific pro-inflammatory effect.
Class A scavenging receptors (SR-A) are a group of receptors 
reported to be involved in the uptake into cells of environmental 
particles, including artificial nanoparticles such as amorphous 
silica nanoparticles (33, 34). Therefore, we examined the effect 
of poly I, a scavenging receptor antagonist, on the induction of 
IL-1β. Poly I treatment enhanced the induction of IL-1β secretion 
in nSP10-, mSP1000-, or crystalline silica-treated cells, but mark-
edly suppressed it in nSP50- or nSP100-treated cells (Figure 5A). 
Since poly I is reported to have inflammatory potential as a ligand 
of toll-like receptor 3 (35), one explanation for this observation 
in poly I-treated cells is that the uptake of nSP50 and nSP100 was 
blocked by poly I, the uptake of nSP10, mSP1000, and crystalline 
silica was completely independent of SR-A, and the inflamma-
tory potential of poly I enhanced IL-1β by nSP10, mSP1000, and 
crystalline silica. To confirm this hypothesis, we examined the 
effect of neutralizing SR-As, namely SR-A1 or MARCO, which is 
reported to be endocytic receptors for particulate matter, on the 
size-specific pro-inflammatory effects of the silica particles (33, 
34). Neutralization of SR-A1 suppressed the induction of IL-1β in 
nSP50- or nSP100-, but not in nSP10-, mSP1000-, or crystalline 
silica-treated cells (Figure  5B). Neutralization of MARCO did 
not affect the induction of IL-1β by the silica particles or crystal-
line silica (Figure 5C). Neutralization of SR-A1 also significantly 
reduced the uptake of nSP50 (P < 0.05) and nSP100 (P < 0.01), 
but not of nSP10, mSP1000, or crystalline silica (Figure  5D). 
Thus, it is likely that the size-specific pro-inflammatory effect of 
the silica particles was a result of SR-A1-mediated endocytosis of 
particles in a specific size range.
A remaining question is why exposure to nSP50 had a greater 
effect on the induction of IL-1β than exposure to nSP100 even 
though both appeared to be taken up via the same receptor. It 
is known that SR-A1 lacks enzymatic activity and intracellular 
signaling motifs, and that it induces Mer receptor tyrosine kinase 
(MerTK) signaling (36). Therefore, we evaluated the contribution 
FigUre 3 | effect of silica particles on caspase-1 activation and pro-il-1β synthesis. Phorbol 12-myristate 13-acetate-differentiated THP-1 cells were 
incubated with zYVAD-fmk (a) or bafilomycin A1 (B) 30 min before the addition of silica particles (50 µg/mL), crystalline silica (500 µg/mL), or adenosine 
5′-triphosphate disodium salt hydrate (ATP, 3 mM). Twenty-four hours after incubation, culture supernatants were collected and interleukin (IL)-1β secretion was 
determined by ELISA. Data are presented as mean ± SD (n = 4 independent cultures/group). N.D., not detected. (c) Phorbol 12-myristate 13-acetate-differentiated 
THP-1 cells were incubated with silica particles (50 µg/mL), crystalline silica (500 µg/mL), or ATP (3 mM) for 6, 12, or 24 h, and pro-IL-1β in the cells was analyzed 
by means of western blotting. (D) The densities of the bands of pro-IL-1β in (c) were quantified by using the ImageJ software (version 1.46r, National Institutes of 
Health). The values of pro-IL-1β were normalized to that of β-actin. Fold induction is relative to the cells only group.
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of MerTK to the induction of IL-1β by nSP50 or nSP100 by 
using UNC569, an inhibitor of the phosphorylation of MerTK 
(37). Inhibition of MerTK signaling markedly suppressed the 
induction of IL-1β by nSP50, but not by nSP100 (Figure  5E). 
Consistent with the effect of neutralizing SR-A1, the induction of 
IL-1β by nSP10-, mSP1000-, or crystalline silica was not blocked 
by UNC569. Together, these results suggest that although the 
uptake of both nSP50 and nSP100 was dependent on SR-A1, 
only nSP50 appeared to induce MerTK signaling, which in turn 
produced a greater induction of IL-1β.
DiscUssiOn
The present results suggest that SR-A1-mediated endocytosis 
underlies silica particle-induced IL-1β secretion, and that the size-
specific pro-inflammatory effects of silica particles are a result of 
the ligand size specificity of this SR-A1-mediated endocytosis. The 
present results also suggest that silica particles with a diameter of 
50 nm induced the strongest pro-inflammatory response. SR-A1 
is known to mediate both pro- and anti-inflammatory responses 
due to its broad ligand specificity (38). However, it remains 
unknown how different ligands produce opposite responses 
via the same receptor. One report has demonstrated that SR-A-
mediated ligand endocytosis is mediated via clathrin-dependent 
and caveolae-dependent pathways, and that each endocytic mode 
has distinct functional consequences via different signaling 
cascades (39). Interestingly, clathrin-mediated and caveolae-
mediated endocytosis are known to be limited to ligands with 
sizes of about 120 and 60 nm, respectively (40). Given these size 
limitations, in the present study, only nSP100 or smaller particles 
could be taken up via clathrin-mediated endocytosis, and only 
nSP50 (or possibly nSP70) or smaller silica particles could be 
taken up by caveolae-mediated endocytosis. Therefore, it is pos-
sible that the ligand size limit of each endocytic mode contributed 
to the particle size-specific effects. Further studies are required to 
FigUre 4 | relationship between uptake of silica particles and interleukin (il)-1β secretion. (a) Phorbol 12-myristate 13-acetate-differentiated THP-1 cells 
were incubated with cytochalasin D 30 min before the addition of silica particles (50 µg/mL) or crystalline silica (500 µg/mL). Twenty-four hours after incubation, 
culture supernatants were collected and IL-1β secretion was determined by ELISA. (B) Phorbol 12-myristate 13-acetate-differentiated THP-1 cells were incubated 
with silica particles (50 µg/mL) for 6, 12, or 24 h. The amount of silicon in the cells was then determined by inductively coupled plasma atomic emission 
spectrometry. Silicon uptake by the cells was calculated as the amount of silicon in silica particle-treated cells minus the amount of silicon in non-treated cells. The 
total particle surface area and number of particles taken up by cells was calculated from information provided in the manufacturer’s data sheet for each type of silica 
particle. Data are presented as mean ± SD (n = 4 independent cultures/group). N.D., not detected.
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elucidate the relationship between each endocytic mode of SR-A 
and the activation of MerTK, which in turn produced the greater 
pro-inflammatory effects.
The results of the present study also suggest that the uptake 
of nSP10 is independent of SR-A1-mediated endocytosis 
(Figure 5D). Small nanoparticles are suggested to be difficult to 
promote multivalent binding by the receptors and thus smaller 
nanoparticles dissociate from the receptors before being taken up 
by cells due to low binding avidity (18). Therefore, it is possible 
that low avidity of nSP10 to SR-A1 cause the independency of 
SR-A1-mediated endocytosis. In addition, for silica particles to be 
ligands of SR-A1 they must be anionic in some extent; therefore, 
the number of silanol groups on the surface of silica particles will 
determine whether or not they are ligands of SR-A1. Since, the 
concentration of silanol groups on the surface of silica nanopar-
ticles increases as particle size decreases (41), the ability of the 
silica particles to bind to SR-A1 must be changed dependent on 
the size. Thus it is also possible that nSP10 is not a ligand of SR-A1 
due to the too much concentration of silanol groups.
The present results suggest that nSP50-mediated MerTK 
signaling increased the induction of IL-1β, although MerTK 
signaling itself is often discussed in an anti-inflammatory, immu-
nosuppressive context mainly due to its relationship to the uptake 
of apoptotic cells by macrophages (42, 43). It has been reported 
that MerTK activation leads to inhibition of the mTOR pathway 
and SR-A1-mediated activation of macrophages (44). Inhibition 
of the mTOR pathway enhances the effects of pro-inflammatory 
cytokines via NF-κB in phagocytic cells after bacterial stimulation 
(45) and of caspase-1 during endotoxin-mediated shock (46). In 
addition, phagocytosis of autophagic dying cells is reported to 
activate the NLRP3 inflammasome rather than inhibit immune 
reactions (47). Thus, in our model, MerTK signaling may induce 
pro-IL-1β and caspase-1 activation, which in turn increases silica 
particle-induced IL-1β secretion. Further studies are required to 
determine how MerTK signaling led to the inflammatory state in 
our model and what phenotype the size-specific effects of silica 
particles result in in vivo.
In previous studies, we observed greater induction of IL-1β 
in THP-1 cells treated with mSP1000 than in those treated 
with smaller particles (i.e., nSP30, nSP50, nSP70, mSP300, and 
mSP1000), although higher concentrations of silica particles were 
used than in the present study (i.e., 100 µg/mL; 6 h incubation) 
(48). However, under the present low-cytotoxic conditions, treat-
ment with mSP1000 induced little IL-1β, even after incubation for 
24 h (Figure 1). Furthermore, under the present conditions, IL-1β 
was detected only at 24 h, irrespective of which silica particle the 
cells were exposed to. Another group has reported that exposure 
to high concentrations (125–500 µg/mL) of silica nanoparticles 
with a diameter of 15  nm induced IL-1β after incubation for 
6 h, and that active ATP release was the underlying mechanism 
FigUre 5 | role of scavenger receptor (sr)-a1 and Mer receptor tyrosine kinase (MerTK) in the size-specific pro-inflammatory effects of silica 
particles. Phorbol 12-myristate 13-acetate-differentiated THP-1 cells were incubated with poly I (a), anti-SR-A1 or its isotype control (mouse IgG1) (B,D), 
anti-MARCO antibody or its isotype control (mouse IgG3) (c), or UNC569 (a specific inhibitor of MerTK) (e) 30 min before the addition of silica particles (50 µg/mL) 
or crystalline silica (500 µg/mL). (a–c,e) Twenty-four hours after incubation, culture supernatants were collected and the concentration of interleukin (IL)-1β was 
determined by ELISA. (D) The amount of silicon in the cells was determined by inductively coupled plasma atomic emission spectrometry. Silicon uptake by the cells 
was calculated as the amount of silicon in treated cells minus the amount of silicon in non-treated cells. Data are presented as mean ± SD (n = 4 independent 
cultures/group). *P < 0.05, **P < 0.01 versus isotype control group. N.D., not detected.
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(26). Interestingly, larger silica particles have also been show to 
produce greater IL-1β induction (4) that is consistent with the 
results of our previous study, where we used high doses of silica 
particles (48). Therefore, it is possible that larger silica particles 
induce greater production of IL-1β than do smaller silica particles 
under high-dose (i.e., high-stress) conditions via an active ATP 
10
Nishijima et al. Size-Specific Effect of Nanoparticles
Frontiers in Immunology | www.frontiersin.org April 2017 | Volume 8 | Article 379
release mechanism. Since active ATP release has been shown to 
be the mechanism underlying the induction of IL-1β by other 
particles (e.g., uric acid, crystalline silica, alum) (Figure S2 in 
Supplementary Material, 6 h incubation) (49), it may have evolved 
to enable cells to rapidly secrete IL-1β. Therefore, it is likely that 
there are two different mechanisms underlying the induction of 
IL-1β by silica particles that are activated only during exposure 
to specific concentrations of silica particles. Further studies are 
required to elucidate whether the slower SR-A1-mediated IL-1β 
secretion observed in the present study involves active ATP 
release.
Scavenger receptors are a potentially useful target for vaccines 
for vaccine development (50, 51). Although elucidation of the 
relationship between the SR-A1-mediated size-specific effects of 
nanoparticles and adjuvanticity is required, optimizing the size 
of the nanoparticles may be a useful way to maximize the effects 
of nanoparticle-mediated vaccines. However, the size-specific 
effects of nanoparticles mean that it is difficult to reliably predict 
the safety of nanoparticles and so individual safety assessments 
will likely be required for each new nanoparticle-based product. 
It is, therefore, important to improve our understanding of the 
size-specific effects of nanoparticles.
The results of the present study suggest that SR-A1-mediated 
uptake of nanoparticles led to a size-specific inflammatory 
response in THP-1 cells. Since nanoparticles also have size-
specific effects in non-phagocytic cells (17–19), there are likely 
additional underlying mechanisms in these cells. Further studies 
to examine the effects of silica and other nanoparticles on a variety 
of cell types would improve our understanding of the size-specific 
effects of nanoparticles. In the present study, nanoparticles with 
a diameter of around 50 nm were found to have the greatest pro-
inflammatory effects, and the size-specific effects of nanoparticles 
of this size are well reported in the literature. Therefore, further 
examination not only of the size-specific effects of nanoparticles 
but also of the possibility that 50  nm is a size that has special 
implications in biological systems in general is needed.
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